Tải bản đầy đủ (.pdf) (35 trang)

cập nhật các hướng dẫn kiểm soát acid uric và bệnh gout từ các khuyến cáo quốc tế

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (4.68 MB, 35 trang )

<span class="text_page_counter">Trang 3</span><div class="page_container" data-page="3">

Prevalence generally ranges from < 1% to 4%

Gout is the most common form of inflammatory arthritis in adults and the second most common form of arthritis (a,c)

US (2011): 8.3 million (gout), 43 million (hyperuricemia)

</div><span class="text_page_counter">Trang 4</span><div class="page_container" data-page="4">

Cácviêm

</div><span class="text_page_counter">Trang 5</span><div class="page_container" data-page="5">

hóa purin và H/C hóa

<small>RLCH Purin gianhanh trong 2 niên</small>

<small>Theo AHA (American Heart Association): </small>

<small>(HK 28,8 % ~ )</small>

</div><span class="text_page_counter">Trang 6</span><div class="page_container" data-page="6">

<i><small>Frances Rees, Michelle Hui & Michael Doherty. Optimizing current treatment of gout. Nature Reviews Rheumatology 10, 271 283 (2014) Published online 11 March 2014 </small></i>

- ACID URIC

Gout

</div><span class="text_page_counter">Trang 9</span><div class="page_container" data-page="9">

<small>(80%-90% of all gout patients)(5%-10% of all gout patients)</small>

Acid Uric

</div><span class="text_page_counter">Trang 10</span><div class="page_container" data-page="10">

Gout: An old disease in new perspective - A review.

<i><small>Gaafar Ragab, MohsenElshahaly, ThomasBardin. Journal of Advanced Research. Volume 8, Issue 5. September 2017, Pages 495-511</small></i>

</div><span class="text_page_counter">Trang 11</span><div class="page_container" data-page="11">

kháng viêm khơng có Steroid (NSAID), Colchine

Allopurinol: 200 800 mg/ngày (TB 300 mg/ngày) Febuxostat: 40 120 mg/ngày (TB 80 mg/ngày)

</div><span class="text_page_counter">Trang 12</span><div class="page_container" data-page="12">

American College of Rheumatology Guidelines for Management of Gout (ACR 2012/2015)

</div><span class="text_page_counter">Trang 15</span><div class="page_container" data-page="15">

máu (HD) = 0.6mg x 2 /1 (not dialyzable)

acid uric tay là nhómmen XO (Xanthine Oxidase Inhibitor- XOI).

tiêu acid uric <6 mg/L là, <5 .

phòng trong 3 tháng (khơng tophi) 6 tháng (có tophi) sau khitiêu acid uric.

</div><span class="text_page_counter">Trang 16</span><div class="page_container" data-page="16">

ACR 2012/2015:- ULT

<small>Khanna D, et al. Arthritis Care Res (Hoboken). 2012 Oct;64(10):1447-61</small>

</div><span class="text_page_counter">Trang 17</span><div class="page_container" data-page="17">

uric ngay

(> 480 mmol/L)

</div><span class="text_page_counter">Trang 18</span><div class="page_container" data-page="18">

EULAR recommendation for Treating to Target 2017

</div><span class="text_page_counter">Trang 19</span><div class="page_container" data-page="19">

2016 EULAR Recommendations for the Management of Gout

<i><small>Richette P et al. Ann Rheum Dis 2017;76:29-42</small></i>

</div><span class="text_page_counter">Trang 20</span><div class="page_container" data-page="20">

2016 EULAR Recommendations for the Management of Gout

<i><small>Richette P et al. Ann Rheum Dis 2017;76:29-42</small></i>

</div><span class="text_page_counter">Trang 21</span><div class="page_container" data-page="21">

The British Society for Rheumatology Guideline for the Management of Gout (BSR 2017)

<i><small>Michelle Hui et al., Rheumatology 2017;56:e1-e20</small></i>

</div><span class="text_page_counter">Trang 22</span><div class="page_container" data-page="22">

<i><small>Schumacher HR Jr, et al. BMJ. 2002;324(7352):1488 1492; Rubin BR, et al. Arthritis Rheum. 2004;50(2):598 606Zhang S & Zhang Y & Liu P. Clin Rheumatol (2016) 35:151 158.</small></i>

</div><span class="text_page_counter">Trang 23</span><div class="page_container" data-page="23">

<i><small>Michelle Hui et al., Rheumatology 2017;56:e1-e20</small></i>

BSR 2017

</div><span class="text_page_counter">Trang 24</span><div class="page_container" data-page="24">

- ACID URIC

<i><small>Improving cardiovascular and renal outcomes in gout: what should we target ? The Lancet Journals. Published Online: 21 April 2016 </small></i>

<small>< 5 mg/dl (< 300 mmol/l)</small>

<small>Gout (Tophi), CKD, CV disease Gout (Ko có tophi, khác) </small>

</div><span class="text_page_counter">Trang 25</span><div class="page_container" data-page="25">

How Gout can Kill You

</div><span class="text_page_counter">Trang 27</span><div class="page_container" data-page="27">

Improving adherence to gout therapy: an expert review

<i><small>Fernando Perez-Ruiz, Giovambattista Desideri. Dove Press Ltd. May 2018 Volume 2018:14 Pages 793802 </small></i>

</div><span class="text_page_counter">Trang 29</span><div class="page_container" data-page="29">

<small>Gout 20 </small>

<small>-Improving adherence to gout therapy: an expert review</small>

</div><span class="text_page_counter">Trang 30</span><div class="page_container" data-page="30">

<small>URAT1Uric acid transporter</small>

<small>MCP-1monocyte chemotactic protein -1NONitric oxidevasodilatation factor</small>

</div><span class="text_page_counter">Trang 33</span><div class="page_container" data-page="33">

sinhnhân Gout

</div><span class="text_page_counter">Trang 34</span><div class="page_container" data-page="34">

1. RLCH Purin và acid uric máu ngày càng gia và liên quan

urate

</div><span class="text_page_counter">Trang 35</span><div class="page_container" data-page="35">

Acid Uric

soát acid uric máu soát acid uric máu

</div>

×